ZaidAbdel RahmanMD

Hematology • Jacksonville, FL

Hematologic Oncology

Physician

Join to view full profile

Dr. Abdel Rahman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Abdel Rahman's full profile

Already have an account?

Office
4500 San Pablo Rd S
Jacksonville, FL 32224
Phone+1 904-953-2000

Summary

Stem Cell Transplantation and Cellular Therapies fellow at MD Anderson Cancer Center

Education & Training

Mayo Clinic College of Medicine and Science (Jacksonville)Fellowship, Hematology and Medical Oncology, 2018 - 2021
Mayo Clinic College of Medicine and Science (Jacksonville)Residency, Hematology and Medical Oncology, 2021
Henry Ford Health/Henry Ford HospitalResidency, Internal Medicine, 2015 - 2018
King Hussein Cancer CenterTransitional year, 2014 - 2015
Hashemite UniversityClass of 2013

Certifications & Licensure

ND State Medical License 2022 - 2024
FL State Medical License 2018 - 2022
MI State Medical License 2015 - 2018
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

ASCO Merit Award Conquer Cancer Foundation of ASCO, 2019

Publications & Presentations

PubMed

7 citations
Comparative study of therapy-related and de novo adult b-cell acute lymphoblastic leukaemia.
Zaid Abdel Rahman, Ricardo D. Parrondo, Michael G. Heckman, Mikolaj Wieczorek, Kevin C. Miller
British Journal of Haematology. 2021-10-25
7 citations
Unique characteristics and outcomes of therapy-related acute lymphoblastic leukemia following treatment for multiple myeloma.
Ricardo D Parrondo, Zaid Abdel Rahman, Michael G Heckman, Mikolaj Wieczorek, Liuyan Jiang
Blood Cancer Journal. 2022-06-01
27 citations
Gilteritinib clinical activity in relapsed/refractory FLT3 mutated acute myeloid leukemia previously treated with FLT3 inhibitors.
Yazan Numan, Zaid Abdel Rahman, Justin Grenet, Stephanie Boisclair, Jan Philipp Bewersdorf
American Journal of Hematology. 2022-03-01

Lectures

Impact of Targeted Immunotherapies and Novel Cytogenetic and Clinical Risk Groups on Outcome after Allogeneic Hematopoietic Stem Cell Transplant (AlloHCT) for Acute Ly...
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Evaluation of etiologic genetic polymorphisms by whole exome sequencing (WES) in the Mayo Clinic AML epidemiology cohort (MCAEC).
2019 ASCO Annual Meeting - 6/1/2019

External Links

LinkedInhttp://www.linkedin.com/in/zaid-abdel-rahman-814565b7